Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.

13 Jul 2010

Rohto launches AFC Medirepair with Signum's compound Arazine in Japan

Signum Biosciences announced that its partner, Rohto Pharmaceutical Co., Ltd., has launched AFC Medirepair® with Signum's compound Arazine™ (n-acetyl-s-farnsylcysteine or AFC) in Japan. Arazine™ is the first compound from Signum's novel anti-inflammatory platform to be commercialized from Signum's pipeline of Signal Transduction Modulators (STMs).

12 Jul 2010

Proper management of asthma during pregnancy reduces risk of harmful effects on babies

Asthma is the most common complication of pregnancy in Australia with harmful effects on babies, but many of these could be prevented a University of Adelaide researcher says.

12 Jul 2010

bitop's Ectoin allergy nasal spray reduces symptoms of acute allergic rhinitis in two-week crossover study

bitop AG, a biotech company specializing in the development of Ectoin®-containing medical devices, reports that Ectoin allergy nasal spray has been shown to significantly reduce symptoms of acute allergic rhinitis in a two-week observational, randomized, comparative crossover study with 50 patients suffering from acute allergic rhinitis. Based on this study, bitop performed a clinical trial on eyes drops and nasal spray in humans using an environmental exposure chamber (EEC) model.

12 Jul 2010

Merck to lay off 15 percent of workers, close plants, research facilities

Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."

9 Jul 2010

Colgate-Palmolive teams up with a trio of Saints to champion good oral health among Gulf Coast children

Colgate's Bright Smiles, Bright Futures national campaign to improve children's oral health joins Super Bowl champions Jonathan Vilma, Pierre Thomas, and Marques Colston and the Boys & Girls Clubs of Southeast Louisiana and Boys & Girls Clubs of the Gulf Coast, to host festivals highlighting the importance of maintaining good oral health. More than 600 children in New Orleans and Mississippi's Hancock and Harrison Counties will receive free dental screenings, oral health education and treatment referrals this weekend. They will also join New Orleans Saints Vilma, Thomas, and Colston in a brush-a-thon to promote oral health awareness.

9 Jul 2010

Study shows association between obesity and GERD in children

Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity.

9 Jul 2010

Que She herbal weight loss supplement contains harmful ingredients, FDA warns

The U.S. Food and Drug Administration today warned that Que She, marketed as an herbal weight loss supplement, contains active pharmaceutical ingredients not listed on the product label that could harm consumers, especially those with cardiovascular conditions.

9 Jul 2010

Article related to MN-166 mechanism of action included in PNAS USA

MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today reported that the June 22, 2010 issue of Proceedings of the National Academy of Sciences USA included an article related to the mechanism of action of MN-166 (ibudilast), as an emerging therapeutic for neurological disorders.

8 Jul 2010

New information about quality of care available in America's hospitals added to new HHS website

Important new information about the quality of care available in America's outpatient and emergency departments, including how well hospitals care for patients with heart attacks and protect outpatients from surgical infections was added to the new HHS website HealthCare.gov.

8 Jul 2010

Study reveals asthma as a risk factor for pneumonia in children hospitalized for influenza

Children with asthma are at increased risk of developing pneumonia as a complication of influenza, reports a study in the July issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

8 Jul 2010

ODA suggests tips for good oral hygiene to parents and kids

The Ontario Dental Association is asking parents to put oral health at the top of their kids camp preparation list. An oral care kit should be on the packing list, complete with a toothbrush, fluoride toothpaste and dental floss.

7 Jul 2010

American Lung Association welcomes U.S. EPA proposal to reduce power plant pollution

The cleanup of power plants is long overdue. Power plant pollution causes tens of thousands of premature deaths each year. These plants are major contributors to particulate pollution and ozone in the East and Midwest. The American Lung Association welcomes today's proposal by the U.S. Environmental Protection Agency to reduce power plant pollution across 31 states.

7 Jul 2010

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.

7 Jul 2010

Westchester Medical Center warns of potential dangers associated with hot weather

The warm weather usually means lots of summer fun and outdoor activities. Unfortunately, the combination of high heat and high humidity often become very dangerous. Temperatures over the next few days are expected to be in the upper 90's with a heat index of over 100 and that can often cause health problems especially in older adults and infants.

3 Jul 2010

FDA issues consumer update on safety alerts

The Food and Drug Administration (FDA) has issued safety alerts about a number of products.

3 Jul 2010

Bronx-Lebanon Hospital Center's new children's outpatient facility named in honor of Alex Rodriguez

Alex Rodriguez joined Bronx-Lebanon Hospital Center President and CEO Miguel A. Fuentes, Jr., as well as board members, staff and pediatric patients at a ceremony to dedicate a new children's outpatient center named in his honor on Wednesday, June 30, 2010.

3 Jul 2010

UCLA study highlights traffic-related asthma flares in urban areas

A new academic study led by UCLA scientists has found that even brief exposure to ultrafine pollution particles near a Los Angeles freeway is potent enough to boost the allergic inflammation that exacerbates asthma.

2 Jul 2010

FDA approves Purdue's Butrans Transdermal System CIII for management of chronic pain

Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.

2 Jul 2010

New asthma therapy shows promise for patients who do not respond to steroid treatments

A new nonsteroidal, anti-inflammatory therapy made from a human protein significantly decreases disease signs of asthma in mice, opening the possibility of a new asthma therapy for patients who do not respond to current steroid treatments. Results of this therapy in an animal model were presented at The Endocrine Society's 92nd Annual Meeting in San Diego.

2 Jul 2010

Asthma News and Research

Further Reading

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Rohto launches AFC Medirepair with Signum's compound Arazine in Japan

Proper management of asthma during pregnancy reduces risk of harmful effects on babies

bitop's Ectoin allergy nasal spray reduces symptoms of acute allergic rhinitis in two-week crossover study

Merck to lay off 15 percent of workers, close plants, research facilities

Colgate-Palmolive teams up with a trio of Saints to champion good oral health among Gulf Coast children

Study shows association between obesity and GERD in children

Que She herbal weight loss supplement contains harmful ingredients, FDA warns

Article related to MN-166 mechanism of action included in PNAS USA

New information about quality of care available in America's hospitals added to new HHS website

Study reveals asthma as a risk factor for pneumonia in children hospitalized for influenza

ODA suggests tips for good oral hygiene to parents and kids

American Lung Association welcomes U.S. EPA proposal to reduce power plant pollution

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

Westchester Medical Center warns of potential dangers associated with hot weather

FDA issues consumer update on safety alerts

Bronx-Lebanon Hospital Center's new children's outpatient facility named in honor of Alex Rodriguez

UCLA study highlights traffic-related asthma flares in urban areas

FDA approves Purdue's Butrans Transdermal System CIII for management of chronic pain

New asthma therapy shows promise for patients who do not respond to steroid treatments

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News